BRAF and malignant conjunctival melanoma: V-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E mutation characterizes up to 50% of conjunctival melanomas as an early event in tumor development [1,2,3,28,29,30,31,32,33,34].